Melanoma Biomarkers May Predict Response to Immunotherapy Melanoma Biomarkers May Predict Response to Immunotherapy
Expression of major histocompatibility complex (MHC) class I and class II proteins may help predict a patient ' s response to melanoma immunotherapy, researchers have found.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer & Oncology | Hematology | Immunotherapy | Melanoma | Skin Cancer